This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Abaloparatide: an anabolic treatment to reduce fracture risk in postmenopausal women with osteoporosis.
Current medical research and opinion, 36(11), 1861-1872
Citation
Miller, Paul D; Bilezikian, John P; Fitzpatrick, Lorraine A; Mitlak, Bruce; McCloskey, Eugene V; Cosman, Felicia; Bone, Henry G. (2020). Abaloparatide: an anabolic treatment to reduce fracture risk in postmenopausal women with osteoporosis.. Current medical research and opinion, 36(11), 1861-1872. https://doi.org/10.1080/03007995.2020.1824897